Changshan Biochemical: Some drugs are planned to be selected for the national centralized procurement drug agreement, and the varieties that have expired will continue to be purchased.

Changshan Biochemical announced that the company will participate in the national organized centralized procurement of drugs when the agreement period expires, with the intention to continue purchasing nadroparin calcium injection and enoxaparin sodium injection. The procurement period will be from the actual implementation date of the selected result until December 31, 2028. The agreed procurement quantity will be based on the demand reported by medical institutions, and the company is unable to determine the exact supply quantity at the moment. The intended selection results still need to be publicly announced and confirmed with no objections, and there are uncertainties in the supply area, quantity, and subsequent matters such as the signing of procurement contracts. The production and sales of drugs are also influenced by multiple factors, which adds certain uncertainties.